Skip to main content

Table 5 Comparison of present series to prospective preoperative chemoradiotherapy trials in gastric cancer

From: Preoperative chemoradiotherapy for locally advanced gastric cancer

Series Patients (n) R0 resection (%)* pCR rate (%)* Overall survival (%)**
M.D. Anderson (Lowy et al.) 24 95 11 N/A
Multi-institutional (Ajani et al.) 33 82 36 54 (2)
M.D. Anderson(Ajani et al.) 41 80 20 N/A
RTOG 9904 (Ajani et al.) 43 75 31 72 (1)
Current series (Pepek et al.) 48 86 19 40 (3)
  1. * Percentages are based on number of patients who underwent surgery after preoperative chemoradiotherapy.
  2. ** Numbers in parentheses are actuarial data in years.